Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iron Supplementation for High Altitude Pulmonary Hypertension
NCT00960921Phase 2Withdrawn
- Sponsor
- University of Oxford
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of iron sucrose in High altitude pulmonary hypertension (HAPH), sponsored by University of Oxford. Status: withdrawn.
02
Drugs
iron sucrose
03
Conditions
High altitude pulmonary hypertension (HAPH)
Beyond the preview
Go deeper on NCT00960921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00960921.